The Efficacy and Safety of Newer Anticonvulsants in Patients with Dementia

Author： Dolder Christian R. Nealy Kimberly L.

ISSN： 1170-229X

Source： Drugs & Aging, Vol.29, Iss.8, 2012-08, pp. : 627-637

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Pilot Study Evaluating the Efficacy and Safety of Rivastigmine in Patients with Mixed Dementia

By Potkin Steven G.

Drugs & Aging, Vol. 23, Iss. 3, 2006-01 ,pp. : 241-249

Adis International

Access to resources Recommend Favorite

Newer Systemic Antifungal Agents: Pharmacokinetics, Safety and Efficacy

By Helen W. Boucher

Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. : 1997-2020

Adis International

Access to resources Recommend Favorite

Dextropropoxyphene: Safety and Efficacy in Older Patients

By Goldstein David J.

Drugs & Aging, Vol. 22, Iss. 5, 2005-01 ,pp. : 419-432

Adis International

Access to resources Recommend Favorite

Newer Anticonvulsants: Comparative Review of Drug Interactions and Adverse Effects

By Sabers A. Gram L.

Drugs, Vol. 60, Iss. 1, 2000-07 ,pp. : 23-33

Adis International

Access to resources Recommend Favorite

Safety and Efficacy of Baclofen in the Treatment of Alcohol-Dependent Patients

Current Pharmaceutical Design, Vol. 16, Iss. 19, 2010-06 ,pp. : 2113-2117

Bentham Science Publishers

Access to resources Recommend Favorite